Glioblastoma multiforme and multiple endocrine neoplasic type 2 A;Glioblastoma multiforme y neoplasia endocrina múltiple tipo 2 A

Medicina Clinica

Volumn 133, Issue 5, 2009, Pages 196-197

  Sánchez Ortiga, Ruth ^a   Boix Carreño, Evangelina ^a   Moreno Pérez, Oscar ^a   Picó Alfonso, Antonio ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; COMORBIDITY; GENE MUTATION; GLIOBLASTOMA; HUMAN; HYPERTHYROIDISM; LETTER; MALE; NODULAR HYPERPLASIA; PUBLICATION; SIPPLE SYNDROME; THYROIDECTOMY;

BRAIN NEOPLASMS; FATAL OUTCOME; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; NEOPLASMS, MULTIPLE PRIMARY; THYROID NEOPLASMS;

EID: 68249143023     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2008.06.021     Document Type: Letter

References (10)

1. J.R. Hansford, and L.M. Mulligan Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis J Med Genet 37 2000 817 827
2. J.W. De Groot, T. Links, J. Plukker, C.J.M. Lips, and R.M. Hofstra RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors Endocr Rev 27 2006 535 560
3. S.J. Marx, and W.F. Simonds Hereditary hormone excess: Genes, molecular pathways, and syndromes Endocr Rev 26 2005 615 661
4. P. Komminoth, P. Roth, S. Muletta-Feurer, P. Saremaslani, W. Seelentag, and P.U. Heitz RET proto-oncogene point mutations in sporadic neuroendocrine tumors J Clin Endocrinol Metab 81 1996 2041 2046
5. F. Lombardo, E. Baudin, E. Chiefari, F. Arturi, S. Bardet, and B. Caillou Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804 J Clin Endocrinol Metab 87 2002 1674 1680
6. O. Gimm, A. Gössling, D.J. Marsh, P.L. Dahia, L.M. Mulligan, and A. Von Deimling Mutation and deletion analysis of GFR alpha-1, encoding the co-receptor for the GDNF/RET complex, in human brain tumours Br J Cancer 80 1999 383 386
7. B. Wiesenhofer, G. Stockhammer, H. Kostron, H. Maier, H. Hinterhuber, and C. Humpel Glial cell line-derived neurotrophic factor (GDNF) and its receptor (GFR-α1) are strongly expressed in human gliomas Acta Neuropathol 99 2000 131 137
8. H. Song, and A. Moon Glial cell-derived neurotrophic factor (GDNF) promotes low-grade Hs683 glioma cell migration through JNK, ERK-1/2 and p38 MAPK signaling pathways Neurosci Res 56 2006 29 38
9. A.N. Verity, T.L. Wyatt, W. Lee, B. Hajos, P.A. Baecker, and R.M. Eglen Differential regulation of glial cell line-derived neurotrophic factor (GDNF) expression in human neuroblastoma and glioblastoma cell lines J Neurosci Res 55 1999 187 197
10. R.F. Ren, J.J. Lah, A. Diehlmann, E.S. Kim, D.B. Hawver, and A.I. Levey Differential effects of transforming growth factor-beta(s) and glial cell line-derived neurotrophic factor on gene expression of presenilin-1 in human post-mitotic neurons and astrocytes Neurosci 93 1999 1041 1049